Line
|
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
118.550
Open
118.550
VWAP
118.55
Vol
1.58K
Mkt Cap
5.23B
Low
118.550
Amount
186.83K
EV/EBITDA(TTM)
7.94
Total Shares
47.10M
EV
6.88B
EV/OCF(TTM)
13.36
P/S(TTM)
1.79
Teleflex Incorporated is a global provider of medical technologies. The Company offers a diverse portfolio with solutions in the therapy areas of anesthesia, emergency medicine, interventional cardiology and radiology, surgical, vascular access, and urology. It primarily designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. It operates in three segments: the Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). Its vascular access product portfolio includes Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous (bone access) systems. Its interventional product offerings consist of a portfolio of Arrow branded intra-aortic balloon pumps and catheters, GuideLiner, Turnpike and TrapLiner catheters, Pulsar-18 T3 Self-Expanding 4F Stent and Orsiro Mission Drug Eluting Stent.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2026Q1
FY2025Q4
FY2025Q3
839.71M
+19.84%
3.168
+8.86%
955.18M
+20.09%
4.056
+4.26%
892.78M
+16.8%
3.402
-2.51%
Estimates Revision
The market is revising Upward the revenue expectations for Teleflex Incorporated (TFX) for FY2025, with the revenue forecasts being adjusted by 5.5% over the past three months. During the same period, the stock price has changed by -8.38%.
Revenue Estimates for FY2025
Revise Upward
+5.5%
In Past 3 Month
EPS Estimates for FY2025
Revise Upward
+4.94%
In Past 3 Month
Stock Price
Go Down
-8.38%
In Past 3 Month
8 Analyst Rating
14.74% Upside
Wall Street analysts forecast TFX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for TFX is 135.86 USD with a low forecast of 128.00 USD and a high forecast of 159.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Buy
5 Hold
1 Sell
Hold
14.74% Upside
Current: 118.410
Low
128.00
Averages
135.86
High
159.00
14.74% Upside
Current: 118.410
Low
128.00
Averages
135.86
High
159.00
Truist
Richard Newitter
Hold
maintain
$123 -> $128
2025-08-04
Reason
Truist
Richard Newitter
Price Target
$123 -> $128
2025-08-04
maintain
Hold
Reason
Truist analyst Richard Newitter raised the firm's price target on Teleflex to $128 from $123 and keeps a Hold rating on the shares. The company's Q2 earnings and revenue beat was a step in the right direction, while the raised EPS guidance implies some improving operational performance amidst FX shifts, the analyst tells investors in a research note.
RBC Capital
Sector Perform
maintain
$130 -> $135
2025-08-01
Reason
RBC Capital
Price Target
$130 -> $135
2025-08-01
maintain
Sector Perform
Reason
RBC Capital raised the firm's price target on Teleflex to $135 from $130 and keeps a Sector Perform rating on the shares. The company's Q2 earnings beat alleviates concerns over downside risk amid operational improvements, the analyst tells investors in a research note. Teleflex's planned business separation remains on track, with management noting continued significant third-party interest in acquiring NewCo, the firm added.
Mizuho
Anthony Petrone
Neutral
maintain
$130 -> $135
2025-08-01
Reason
Mizuho
Anthony Petrone
Price Target
$130 -> $135
2025-08-01
maintain
Neutral
Reason
Mizuho analyst Anthony Petrone raised the firm's price target on Teleflex to $135 from $130 and keeps a Neutral rating on the shares. The company reported strong Q2 results, the analyst tells investors in a research note.
Mizuho
Anthony Petrone
Neutral
downgrade
$150 -> $130
2025-07-16
Reason
Mizuho
Anthony Petrone
Price Target
$150 -> $130
2025-07-16
downgrade
Neutral
Reason
Mizuho analyst Anthony Petrone lowered the firm's price target on Teleflex to $130 from $150 and keeps a Neutral rating on the shares. The firm adjusted price targets in medical devices and diagnostics ahead of the Q2 reports.
RBC Capital
Shagun Singh
Sector Perform
downgrade
$145 -> $130
2025-07-15
Reason
RBC Capital
Shagun Singh
Price Target
$145 -> $130
2025-07-15
downgrade
Sector Perform
Reason
RBC Capital analyst Shagun Singh lowered the firm's price target on Teleflex to $130 from $145 and keeps a Sector Perform rating on the shares as part of a broader research note previewing Q2 results for MedTech names. Based on the firm's intra-quarter diligence with key opinion leaders and company management / investor discussions, there is a high level of interest in MedTech and multiple opportunities across the sector, the analyst tells investors in a research note. Regarding the company however, the firm notes that investors are on the sidelines on Teleflex after the guidance reduction on the prior call due to tariffs and business separation that is not until mid-2026.
Truist Securities
Richard Newitter
Hold
Maintains
$149 → $140
2025-04-11
Reason
Truist Securities
Richard Newitter
Price Target
$149 → $140
2025-04-11
Maintains
Hold
Reason
Truist lowered the firm's price target on Teleflex to $140 from $149 and keeps a Hold rating on the shares as part of a broad research note previewing Q1 results in Medical Technology. The group's revenue and earnings are less at risk than it could be for a number of other sub-sectors, which will likely keep investors relatively interested in the space even with some tariff choppiness in the backdrop, though the firm is also bracing for cautious 2025 outlooks as companies and models will likely begin to dial-in some macro uncertainty, the analyst tells investors in a research note.
See All Ratings
Valuation Metrics
The current forward P/E ratio for Teleflex Inc (TFX.N) is 8.19, compared to its 5-year average forward P/E of 20.00. For a more detailed relative valuation and DCF analysis to assess Teleflex Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
Undervalued
5Y Average PE
20.00
Current PE
8.19
Overvalued PE
26.90
Undervalued PE
13.10
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
Undervalued
5Y Average EV/EBITDA
16.41
Current EV/EBITDA
7.46
Overvalued EV/EBITDA
21.56
Undervalued EV/EBITDA
11.27
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
Undervalued
5Y Average PS
4.29
Current PS
1.42
Overvalued PS
5.79
Undervalued PS
2.78
Financials
Annual
Quarterly
FY2025Q2
YoY :
+4.16%
780.89M
Total Revenue
FY2025Q2
YoY :
+42.29%
177.48M
Operating Profit
FY2025Q2
YoY :
+52.91%
122.58M
Net Income after Tax
FY2025Q2
YoY :
+63.91%
2.77
EPS - Diluted
FY2025Q2
YoY :
-147.08%
-26.78M
Free Cash Flow
FY2025Q2
YoY :
-0.63%
55.20
Gross Profit Margin - %
FY2025Q2
YoY :
-6.51%
13.06
FCF Margin - %
FY2025Q2
YoY :
+46.87%
15.70
Net Margin - %
FY2025Q2
YoY :
-33.94%
3.97
ROIC
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
5
633.6K
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds areSelling! The selling amount has increased 143.92% over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
12.4K
Volume
1
6-9
Months
5.1K
Volume
1
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
4
300.6K
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
16.0K
USD
2
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
5
633.6K
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
TFX News & Events
Events Timeline
2025-07-31 (ET)
2025-07-31
06:36:45
Teleflex raises FY25 adjusted EPS view to $13.90-$14.30 from $13.20-$13.60
2025-07-31
06:35:22
Teleflex reports Q2 adjusted EPS $3.73, consensus $3.37
2025-06-12 (ET)
2025-06-12
06:34:54
Teleflex reports results from study of Arrow Chlorhexidine-Impregnated CVCs
Sign Up For More Events
Sign Up For More Events
News
4.0
08-01BenzingaDeep Dive Into Teleflex Stock: Analyst Perspectives (7 Ratings)
9.5
07-31NewsfilterTeleflex Incorporated (TFX) Q2 2025 Earnings Conference Call Transcript
7.0
07-31NASDAQ.COMTeleflex Boosts FY25 Outlook, Declares Dividend - Update
Sign Up For More News
People Also Watch
CHE
Chemed Corp
435.045
USD
-0.07%
GPK
Graphic Packaging Holding Co
22.660
USD
-0.35%
FLS
Flowserve Corp
52.200
USD
+0.12%
AES
AES Corp
12.850
USD
-2.06%
RH
RH
217.800
USD
+1.28%
CRL
Charles River Laboratories International Inc
148.900
USD
+0.11%
MKTX
Marketaxess Holdings Inc
187.230
USD
+0.12%
PAC
Grupo Aeroportuario del Pacifico SAB de CV
241.220
USD
+0.12%
HLNE
Hamilton Lane Inc
154.700
USD
+0.10%
IONQ
IONQ Inc
44.660
USD
+6.71%
FAQ
What is Teleflex Inc (TFX) stock price today?
The current price of TFX is 118.41 USD — it has increased 0 % in the last trading day.
What is Teleflex Inc (TFX)'s business?
What is the price predicton of TFX Stock?
What is Teleflex Inc (TFX)'s revenue for the last quarter?
What is Teleflex Inc (TFX)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for Teleflex Inc (TFX)'s fundamentals?
How many employees does Teleflex Inc (TFX). have?